Additionally, there is compelling evidence to suggest that purification of CD34+ progenitors during allogeneic donation effectively minimizes GVHD and may reduce relapse incidence (Lang et al, 2003; Lee et al, 2005). The gene discussed is CD34; the disease is graft versus host disease.